• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于测量细胞介导的同种异体移植和肿瘤对少量贴壁靶细胞免疫的同位素释放测定法和末端标记测定法。

An isotope-release assay and terminal-labeling assay for measuring cell-mediated allograft and tumor immunity to small numbers of adherent target cells.

作者信息

Tamerius J D, Garrigues H J, Hellström I, Hellström K E

出版信息

J Immunol Methods. 1978;22(1-2):1-22. doi: 10.1016/0022-1759(78)90054-6.

DOI:10.1016/0022-1759(78)90054-6
PMID:78950
Abstract

A 51Cr-release assay and terminal 51Cr-labeling assay for measuring cell-mediated immunity to adherent target cells is described. Both techniques utilize small 10 microliter-per well microtiter plates, require low numbers of target cells (50-500 per well), and consequently, relatively small numbers of effector cells per well (3x10(3) -1x10(5)). Both assays are objective, quantitative, and simple to perform. The suitability of these techniques for monitoring immunologically specific, cellmediated, cytotoxic response to syngeneic and allogeneic tumor cells and normal skin fibroblasts is demonstrated. Lymph node cells, spleen cells and peritoneal exudate cells serve as effectors.

摘要

本文描述了一种用于测量针对贴壁靶细胞的细胞介导免疫的51Cr释放试验和终末51Cr标记试验。这两种技术均使用每孔10微升的小型微量滴定板,所需靶细胞数量少(每孔50 - 500个),因此每孔效应细胞数量也相对较少(3×10³ - 1×10⁵个)。两种试验均客观、定量且操作简单。证明了这些技术适用于监测对同基因和异基因肿瘤细胞以及正常皮肤成纤维细胞的免疫特异性、细胞介导的细胞毒性反应。淋巴结细胞、脾细胞和腹腔渗出细胞可作为效应细胞。

相似文献

1
An isotope-release assay and terminal-labeling assay for measuring cell-mediated allograft and tumor immunity to small numbers of adherent target cells.一种用于测量细胞介导的同种异体移植和肿瘤对少量贴壁靶细胞免疫的同位素释放测定法和末端标记测定法。
J Immunol Methods. 1978;22(1-2):1-22. doi: 10.1016/0022-1759(78)90054-6.
2
A microcytotoxicity assay using 51Cr for measuring specific cell-mediated and humoral immune responses.一种使用51Cr的微量细胞毒性试验,用于测量特异性细胞介导和体液免疫反应。
Int Arch Allergy Appl Immunol. 1979;60(3):332-45. doi: 10.1159/000232359.
3
Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity.小鼠淋巴细胞对同基因酸性异基因肿瘤的天然细胞毒性反应。I. 反应性和特异性的分布
Int J Cancer. 1975 Aug 15;16(2):216-29. doi: 10.1002/ijc.2910160204.
4
Secondary cell-mediated cytotoxic response to challenge of rats with syngeneic Gross virus-induced lymphoma.用同基因格罗斯病毒诱导的淋巴瘤对大鼠进行攻击后产生的继发性细胞介导细胞毒性反应。
J Natl Cancer Inst. 1976 Jun;56(6):1211-5. doi: 10.1093/jnci/56.6.1211.
5
Susceptibility of adherent versus suspension target cells derived from adherent tissue culture lines to cell-mediated cytotoxicity in rapid 51Cr-release assays.在快速51Cr释放试验中,源自贴壁组织培养系的贴壁靶细胞与悬浮靶细胞对细胞介导的细胞毒性的敏感性。
J Immunol Methods. 1980;32(2):127-39. doi: 10.1016/0022-1759(80)90066-6.
6
In vitro induction of tumour-specific immunity. I. Development of optimal conditions for induction and assay of cytotoxic lymphocytes.肿瘤特异性免疫的体外诱导。I. 细胞毒性淋巴细胞诱导和检测最佳条件的建立。
J Immunol Methods. 1975;8(1-2):133-49. doi: 10.1016/0022-1759(75)90090-3.
7
An in vitro assay of cell-mediated cytotoxicity. Terminal labeling with 3h-leucine.
Transplantation. 1976 Oct;22(4):337-44. doi: 10.1097/00007890-197610000-00004.
8
A long-term 51chromium assay for in vitro cell-mediated tumor immunity. Correlation with simultaneously performed microplate assays.一种用于体外细胞介导肿瘤免疫的长期⁵¹铬检测法。与同时进行的微孔板检测法的相关性。
Int J Cancer. 1975 Oct 15;16(4):682-93. doi: 10.1002/ijc.2910160419.
9
In vitro studies on cell-mediated cytotoxicity by means of a terminal labeling technique.利用末端标记技术进行的细胞介导细胞毒性的体外研究。
Cell Immunol. 1975 Feb;15(2):382-91. doi: 10.1016/0008-8749(75)90016-7.
10
Evaluation of 51Cr release for detecting cell-mediated cytotoxic responses to solid chemically induced rat tumours.评估51铬释放以检测对化学诱导的大鼠实体瘤的细胞介导细胞毒性反应。
Br J Cancer. 1977 Jun;35(6):834-43. doi: 10.1038/bjc.1977.126.

引用本文的文献

1
T-T hybridoma product specifically suppresses tumor immunity.T-T杂交瘤产物可特异性抑制肿瘤免疫。
Proc Natl Acad Sci U S A. 1980 May;77(5):2866-70. doi: 10.1073/pnas.77.5.2866.